Objectives: To determine the fasting plasma concentrations of quercetin, hesperetin and naringenin in human subjects consuming their habitual diets, and diets either high or low in fruit and vegetables. To investigate whether plasma concentrations of flavanones can serve as biomarkers of their intake. Design: This was a cross-over, strictly controlled dietary intervention consisting of a 2 week baseline period, and two 5 week dietary periods with a 3 week wash-out period in between. The low-vegetable diet contained few fruit and vegetables and no citrus fruit. The high-vegetable diet provided various fruits and vegetables daily including on average one glass of orange juice, one-half orange and one-half mandarin. Subjects: Thirty-seven healthy females. Results: The high-vegetable diet provided 132 mg of hesperetin and 29 mg of naringenin. The low-vegetable diet contained no flavanones. The mean plasma hesperetin concentration increased from 12.2 nmol=l after the low-vegetable diet to 325 nmol=l after the high-vegetable diet. The respective increase for naringenin was from < 73.5 nmol=l for all subjects to a mean value of 112.9 nmol=l. The mean plasma quercetin concentration was 52 nmol=l after the baseline period, during which habitual diets were consumed, and it did not change significantly during the intervention. Interindividual variation in the plasma levels of hesperetin and naringenin was marked and, after the baseline and wash-out periods, and the low-vegetable diet, a majority of the samples had plasma flavanone levels below the limit of detection. After the high-vegetable diet, hesperetin and naringenin were detectable in 54 and 22% of all samples. Quercetin was detectable in nearly all samples after all study periods. Conclusion: Hesperetin, naringenin and quercetin are bioavailable from the diet, but the plasma concentrations of hesperetin and naringenin are poor biomarkers of intake.
Introduction
Epidemiological studies suggest that a diet high in vegetables and fruit protects against chronic diseases such as cardiovascular diseases and cancer. What role individual compounds play in this protection and to what extent they account for the decreased risk of diseases is not known. Fruit and vegetables contain a variety of potentially beneficial nutrients such as vitamins C and E, but also many so called nonnutrients such as flavonoids.
Several epidemiological studies indicate an inverse association between the intake of flavonols (a subgroup of flavonoids) and the risk of cardiovascular disease (Hertog et al, 1993 (Hertog et al, , 1995 Knekt et al, 1996; Yochum et al, 1999) . The most abundant flavonol in the diet is quercetin, which possesses biological activities such as antioxidative (Chopra et al, 2000; Fuhrman & Aviram, 2001) , anticarcinogenic (Pereira et al, 1996; Caltagirone et al, 1997) and enzyme-inhibiting activities (Siess et al, 1995; Agullo et al, 1997; Conseil et al, 1998) . Other flavonoid subgroups of interest are for instance the flavanones. Flavanones also possess promising biological properties and their dietary intake is quite high in individuals consuming citrus products regularly. The main dietary flavanones are hesperetin and naringenin, which occur almost exclusively in citrus fruits. Glycoside forms of these compounds are present in high concentrations (several hundred mg=kg) in many commonly consumed citrus fruits and juices (Rouseff et al, 1987; Mouly et al, 1998) . In Finland, the average intake of hesperetin has been estimated to be 28.3 mg=day, and for naringenin the estimate is 8.3 mg=day (Kumpulainen et al, 1999) .
Some epidemiological studies have suggested a protective association between a high consumption of citrus and different types of cancer (De Stefani et al, 2000; Voorrips et al, 2000) and ischemic stroke (Joshipura et al, 1999) . Experimental studies indicate that hesperetin and naringenin may play a role in this protection. Feeding of orange juice, grapefruit juice or pure flavanones has been shown to inhibit several types of chemically induced carcinogenesis in laboratory animals (So et al, 1996 Yang et al, 1997) . The mechanisms of action are unclear, but hesperetin and=or naringenin have been reported to inhibit estrone sulfatase (Huang et al, 1997) and cytochrome P-450 isoenzymes (Ghosal et al, 1996) , to bind to estrogen receptors (Kuiper et al, 1998; Hunter et al, 1999) and to sex hormonebinding globulin (Dechaud et al, 1999) , and to act as antioxidants (van Acker et al, 2000; Fuhrman & Aviram, 2001 ). Furthermore, flavanones have been shown to affect cholesterol metabolism in rats (Bok et al, 1999) and in HepG2 cells (Borradaile et al, 1999) , and in a recent study, ingestion of orange juice increased HDL cholesterol levels in hypercholesterolemic human subjects (Kurowska et al, 2000) .
Flavonoids usually occur in plants as glycosides. Quercetin occurs in several different glycosidic forms in plants, but the flavanone glycosides are less numerous. It has been shown that quercetin is bioavailable from foods such as onions, tea and apples (Hollman et al, 1997) , which are its main dietary sources (Hertog et al, 1995) . It has also been shown that hesperetin and naringenin are bioavailable from citrus (Ameer et al, 1996; Erlund et al, 2001) . It is evident that the bioavailability of quercetin, and most likely of other flavonoids as well, is greatly affected by the type and binding site of the sugar moieties (Hollman et al, 1999) . On the whole, few data are available concerning plasma flavonoid concentrations in subjects following their habitual diets.
To our knowledge, no information is available about plasma flavanone concentrations after long-term consumption of citrus or in subjects consuming their habitual diets, and data on plasma quercetin concentrations are mainly derived from studies in which rather high amounts of quercetin-rich foods were consumed.
The aim of this study was to determine the plasma concentrations of hesperetin, naringenin and quercetin in human subjects consuming their habitual diets, and diets either low or high in fruit and vegetables. We also wanted to study the possibility of using plasma concentrations of flavanones as biomarkers of their intake. The diets were originally designed to be high or low in folate, vitamin C, vitamin E and carotenoids, and the biochemical effects of the diets are reported elsewhere (Silaste et al, 2001 ).
Methods

Subjects
Thirty-seven healthy women working at the University Hospital of Oulu participated in the study. They were between 22 and 57 y of age (mean 43 y) and their height and weight ranged from 155 to 172 cm (mean 163 cm) and from 51.8 to 78.0 kg (mean 63.6 kg), respectively. Screening clinical chemistry tests, a physician's examination and a dietician's interview were performed during the baseline period. Inclusion criteria were as follows; the subject had no gastrointestinal, renal or hepatic disease, had normal blood glucose and lipid concentrations, had a body mass index between 20 and 29 kg=m 2 , had no food allergies, consumed alcohol with moderation, was not a current smoker, pregnant or lactating and did not use dietary supplements during the 6 months preceding the study. Six subjects used oral contraceptives and three subjects were on hormone replacement therapy. Two subjects took antibiotics during the study; one subject used flucaconazol during the low-vegetable diet and one subject took amoxicillin for 10 days during the high-vegetable diet (the last dose was taken 17 days before the end of diet 2).
The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants, and the study was approved by the Ethical Committee of the Faculty of Medicine, University of Oulu.
Study design
This cross-over study consisted of a 2 week baseline period and two 5 week intervention periods with a 3 week wash-out period in between. During the baseline and wash-out periods, the subjects followed their habitual diets. At the end of the baseline, the subjects were randomized into two groups. One group was first on the low-vegetable diet and then on the high-vegetable diet, and the other group had the order of the two diets reversed. All food and beverages were provided by the hospital kitchen. Lunches and dinners were served at the hospital cafeteria, or the participants could take the packaged meals home.
Diets
Both diets were designed on the basis of regular hospital meals. The low-vegetable diet was designed to provide 60 mg of vitamin C, 8 mg of vitamin E and 200 mg of folate per day. The intake of other nutrients was designed to meet the Plasma concentrations of flavonoids I Erlund et al Nordic nutrition recommendations. During the low-vegetable diet one serving of fresh vegetables and fruit or fruit juices, but no citrus fruits or juices, was served daily. The high-vegetable diet was designed to provide 480 mg of vitamin C, 16 mg of vitamin E, 10 mg of b-carotene and 600 mg of folate daily. During the high vegetable diet, several servings of vegetables and fruit such as cabbage, cauliflower, broccoli, red pepper, carrots, peas, broccoli, kiwi, strawberries or black currants were provided daily. The diet also provided moderate amounts of citrus products. On average, the subjects received 211 g of orange juice, one-half orange, and one-half mandarin per day. Mandarines were not served on the day before sample collection.
Dietary analyses
Four-day diet records were kept during the baseline diet period. Each day, duplicate portions of the intervention diets were collected and aliquots of the diets were homogenized and frozen ( 7 20 C). At the end of study, the frozen food samples were thawed and combined to give four pooled samples. The nutrient contents of the diets, including hesperetin, naringenin and quercetin, were analysed from the duplicate portions at the Agricultural Research Center of Finland (Jokioinen, Finland). Flavonoids were extracted and analysed according to the method of Hertog et al (1992) with a minor modification (a gradient was used in high-performance liquid chromatography). The limit of quantitation for the analysis of the flavonoids in question was 2 mg=100 g of fresh weight of diet. As the naringenin concentrations of the diets were below the limit of quantitation of the method, the intake of naringenin was estimated by multiplying the hesperetin content of the diet by 0.22. This is in accordance with results by Rouseff et al (1987) and results from our own laboratory regarding the flavanone content of citrus juices sold in Finland (unpublished).
Analysis of plasma flavonoids
Blood was drawn by venipuncture from the antecubital vein in the morning after an overnight fast into EDTA-containing tubes. The serum was separated immediately and was kept frozen at 7 70 C until analysed. Plasma flavonoid concentrations were analysed as reported previously (Erlund et al, 1999 (Erlund et al, , 2001 ). In brief, 0.5 ml of plasma was incubated with 55 ml of 0.78 mol=l sodium acetate buffer (pH 4.8), 50 ml of 0.1 mol=l ascorbic acid and 20 ml of a crude enzyme preparation from Helix pomatia (type HP-2, Sigma), for 17 h at 37 C. Flavonoids were extracted from plasma proteins using Bond Elut C 18 solid-phase extraction columns and they were analyzed by reversed-phase high-performance liquid chromatography with electrochemical detection. In plasma, the flavonoids are most likely to be conjugated to glucuronic acid and sulphate groups and are less likely to be present as intact flavonoid glycosides. The type of hydrolyzing enzyme used cleaves all of the above-mentioned conjugates and therefore the results represent total hesperetin, naringenin and quercetin concentrations.
Statistical analyses
Statistical analyses were performed using SPSS 10.0 for Windows. Because the data were not normally distributed, nonparametric statistical methods were used. For the same reason the results are given as means without standard deviations or standard errors. Whether the four periods differed was tested by Friedmans test (the non-parametric equivalent of a one-sample repeated measures design). This was done for each flavonoid separately. Wilcoxon signed rank test was used to test the difference between the highand low-vegetable diets. A P-value of less than 0.05 was considered statistically significant. Pearson's and Spearman's correlations between quercetin intake and plasma concentrations were calculated for the baseline values. The corresponding values for flavanones were not calculated due to the small number of subjects with detectable levels of flavanones in plasma at baseline.
Results
The intakes of the studied flavonoids and other dietary components are shown in Table 1 . Quercetin was obtained from the baseline diet by all subjects, and hesperetin and naringenin were obtained by approximately 40% of the The number of subjects of all subjects consuming citrus products containing the compound. f Below limit of detection. g Calculated by multiplying the value for hesperetin with 0.22 (analyzed also from duplicated portions but levels below limit of detection, l.d.).
Plasma concentrations of flavonoids I Erlund et al subjects (60% of the subjects did not consume citrus during the days food records were kept). On the high-vegetable diet the daily intake of hesperetin was 132 mg (analyzed from the composite sample of duplicate portions) and for naringenin the estimated intake was 29 mg. On the low-vegetable diet, the intakes of hesperetin and naringenin were < 46 mg=day (ie the flavonoid concentrations in the composite samples of the duplicate portions were below the limit of quantitation of the analytical method). Quercetin intake was below 46 mg=day on both intervention diets. In general, the intake of nutrients met the targets set for the diets. The mean plasma hesperetin, naringenin and quercetin concentrations measured after the two intervention diets and during the baseline diet are shown in Table 2 . It should be noted that, when calculating the mean values, the samples with plasma concentrations below the limit of detection have been denoted the value zero. The mean plasma hesperetin concentrations increased from 12.2 nmol=l after diet 1 to 325 nmol=l after diet 2 (P < 0.001). The corresponding increase for naringenin was from < 73.5 nmol=l for all subjects to a mean of 112.9 nmol=l (P < 0.01). Plasma quercetin concentrations decreased after both the low-and high-vegetable diets compared to the baseline and wash-out periods and they were slightly higher after the high-vegetable diet compared to the lowvegetable diet. Friedman's test for repeated measures gave the following results for plasma concentrations of the three flavonoids: plasma hesperetin (P < 0.001) and naringenin (P ¼ 0.01) concentrations after the four periods differed significantly, but differences in plasma quercetin concentrations were non-significant (P > 0.05).
The distribution of plasma flavonoid concentrations are shown in Figure 1 . After the baseline and the wash-out periods, and the low-vegetable diet, most plasma samples had flavanone concentrations below the limit of detection (73 and 33 nmol=l for naringenin and hesperetin, respectively). After the high-vegetable diet, hesperetin was detectable in 54% of the samples, but naringenin in only 22% of the samples. Quercetin, on the other hand, was present in nearly all plasma samples after all periods. After the highvegetable diet the detectable values for hesperetin ranged between 40 and 2958 nmol=l. The corresponding range for naringenin was 90 -2120 nmol=l and for quercetin it was 7 -214 nmol=l.
The five subjects having the highest plasma concentrations of hesperetin also had the highest concentrations of naringenin. No correlation between calculated intake and plasma concentrations was found for quercetin during the baseline period (Pearson's correlation r ¼ 0.14, Spearman's correlation r ¼ 0.23).
Discussion
This is the first report on plasma hesperetin and naringenin concentrations in human subjects after long-term consumption of citrus fruit and juices. It is also one of the first reports on plasma quercetin concentrations in subjects consuming diets similar to the habitual diets of the general population. Hesperetin and naringenin were bioavailable from the highvegetable diet (containing moderate amounts of citrus). However, interindividual variation in plasma concentrations was considerable and, presumably because of the short halflife of the compounds, a large number of the samples obtained after an overnight fast had flavanone levels below the limit of detection. The plasma quercetin concentrations decreased (non-significantly) on both the high-and lowvegetable diets in this dietary intervention, which was originally designed to study the effects of changing the dietary intakes of folate, vitamins C and E, and carotenoids.
We have previously shown that plasma quercetin can be used as a biomarker of its intake (Erlund et al, 2000) . We have also recently developed analytical methods which for the first time allow the analysis of flavanones in plasma and, using a single-dose approach, conducted a pharmacokinetic study to investigate whether flavanones are suitable for use as biomarkers of intake (Erlund et al, 2001) . In that study the peak plasma concentrations of the flavanones were relatively high; the mean peak plasma concentrations after one-time ingestion of citrus juices (8 ml=kg) were 6.0 mmol=l (1628 mg=l) for naringenin from grapefruit juice, and 2.2 mmol=l (655 mg=l) and 0.6 mmol=l (175 mg=l) for hesperetin and naringenin from orange juice. The elimination half-lives of the compounds were, however, relatively short (1.3 -2.2 h) and interindividual variation in bioavailability remarkable. These results suggested that, because of the unfavorable kinetic behaviour of the compounds, the use of plasma, and especially urine, flavanone concentrations as biomarkers of flavanone intake could be problematic.
In this study, the mean plasma concentrations of naringenin and hesperetin were significantly higher after the high-vegetable diet compared to their concentrations after the low-vegetable diet. As expected, since the low-vegetable diet did not contain citrus products, none of the subjects on Table 2 Plasma flavonoid concentrations after the baseline period (2 weeks), the low-vegetable diet (5 weeks, containing low amounts of vegetables and fruit, and no citrus), the wash-out period (3 weeks) and the high-vegetable diet (5 weeks, containing high amounts of vegetables and fruit, including moderate amounts of citrus). The results are given as nmol=l
Hesperetin
Naringenin Quercetin Plasma concentrations of flavonoids I Erlund et al the low-vegetable diet had measurable levels of naringenin in plasma, and the mean hesperetin concentration was very low (12.2 nmol=l). This indicates that the subjects adhered to the dietary instructions well, except for a few minor deviations.
After the high-vegetable diet, a large number of subjects had plasma flavanone levels below the limit of detection of the method (73 and 33 nmol=l for naringenin and hesperetin, respectively; Table 2 ). There could be several reasons why flavanones were not present in plasma of all subjects consuming citrus. First of all, interindividual variation in the bioavailability of flavanones is remarkable (Erlund et al, 2001) . This variation could be caused by differences in the intestinal microflora. The factors affecting the amount of bacteria producing enzymes capable of hydrolysing hesperidin and narirutin (the main flavanone glycosides in oranges and mandarines) or modulating the activities of such enzymes, are not known. Another explanation of the great variation in plasma concentrations is that, although the diet was controlled, the subjects did not eat exactly the same amounts of oranges=orange juice at exactly the same timepoints. Because of the short half-life of the compounds, such Figure 1 Distribution of plasma hesperetin, naringenin and quercetin concentrations after the baseline period, the low-vegetable diet, the wash-out period and the high-vegetable diet.
Plasma concentrations of flavonoids I Erlund et al factors inevitably affect the concentrations of flavanones in fasting plasma samples taken the following morning. However, we did not find differences between the time of intake of citrus and plasma flavanone concentrations (data not shown). The elimination half-lives of naringenin and hesperetin vary little between individuals (Erlund et al, 2001) and it is unlikely that the compounds would have been excreted more quickly in some subjects than in others. This indicates that the major factor affecting the plasma levels was in fact interindividual variation in the bioavailability of the compounds.
The results of this and our previous pharmacokinetic study (Erlund et al, 2001) do not give an answer to the following questions: do flavanones accumulate in plasma after long-term intake, and are they distributed to tissues other than plasma and urine. High concentrations of flavanones in plasma of all or many subjects would have indicated accumulation. The results of this study do not indicate that accumulation in plasma occurs, especially since 17 and 29 subjects, respectively, had plasma hesperetin and naringenin concentrations below the limit of quantitation after the citrus-containing diet. However, distribution and accumulation of flavanones in other tissues cannot be ruled out, because compounds taken into cells could be released back into the bloodstream at concentrations below the limit of detection of the analytical method, or as metabolites or degradation products. Furthermore, it is possible that, in the subjects absorbing flavanones efficiently, accumulation in plasma did occur.
In the present study, the mean hesperetin and naringenin concentration in plasma samples obtained after an overnight fast were comparable to the peak plasma concentration of many other flavonoids after consumption of foods containing them (Scalbert and Williamson, 2000) . Furthermore, the results of our previous pharmacokinetic study showed that after ingestion of orange juice or grapefruit juice, the resulting plasma concentrations of flavanones are relatively high in subjects absorbing them efficiently (Erlund et al, 2001) . Therefore, if the biological activities ascribed to the compounds actually prevail in vivo, significant health effects could take place in individuals consuming citrus fruits and juices. However, due to the short half-life of the compounds the consumption would probably have to be regular, although, if accumulation into tissues occurs, even a less regular consumption could result in health effects.
The plasma quercetin concentrations decreased slightly from the baseline and the wash-out values during both the high-and low-vegetable diets, although the differences were not statistically significant. The decrease was probably caused by the fact that the study diets contained less onions than the habitual diets of the volunteers. Onion is the most important source of quercetin and, to our knowledge, the compound is much more bioavailable from onion than from any other source yet studied. The mean quercetin concentration was only slightly (and not significantly) higher after the high-vegetable diet than after the lowvegetable diet. This is not surprising since the percentage increase in intake of quercetin from the high-vegetable diet compared to the low-vegetable diet was rather small, since the high-vegetable diet contained mostly fruit and vegetables low in quercetin. On the whole, the results of this study regarding quercetin are a good reminder of the fact that, when modifying diets in order to alter the intake of certain nutrients, the intake and tissue concentrations of other potentially beneficial dietary components can be affected in a less desirable way.
One of our main interests is to study the association between tissue concentrations of dietary components and the risk of chronic diseases. According to our results hesperetin and naringenin are poor biomarkers of their intake, and it is possible that combining plasma concentrations with disease data could yield inaccurate results regarding the possible protective effect of flavanones on chronic diseases. A more sensible way would be to combine intake data of citrus (obtained by dietary assessment methods) with disease data. This approach is supported by the fact that citrus products are not usually hidden in other foods, and by the assumption that individuals consuming citrus fruits or juices probably do so quite regularly. Therefore, individuals should be able to estimate their citrus consumption fairly accurately. However, the fact remains that dietary assessment methods do not take into account differences in bioavailability, and as long as there is no information available on which factors affect it, corrections for differences in bioavailability cannot be made. Therefore it is difficult to say how accurate the results obtained by this method actually are. The situation is quite different for flavanones than it is for quercetin. The intake of the quantitatively and qualitatively most important source of quercetin, ie onion, is difficult to estimate because onion is a commonly used 'hidden' ingredient of many processed and home-made foods. Therefore it was not surprising that we could not find a correlation between quercetin intake and its plasma concentrations. When studying the associations between quercetin and chronic diseases, linking together plasma concentrations and disease data may give more accurate results than when only intake data, obtained by dietary assessment methods, are linked with disease data. We (Erlund et al, 2000) and others (De Vries et al, 1998) have previously shown that plasma quercetin concentration can be used as a biomarker of its intake. Plasma quercetin concentrations increase dose-dependently and the elimination half-life is relatively long. On the whole, when investigating the associations between flavonoids and the risk of diseases, it would be advisable to combine both dietary intake data and plasma concentrations with disease data. Both methods have their shortcomings, but the sources of error are different.
In conclusion, our results show that quercetin, naringenin and hesperetin are bioavailable from diets resembling the habitual diets of the general population. The results also indicate that plasma flavanone concentrations are poor biomarkers of intake.
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